Literature DB >> 11561226

Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.

P M Jakobs1, E L Hanson, K A Crispell, W Toy, H Keegan, K Schilling, T B Icenogle, M Litt, R E Hershberger.   

Abstract

BACKGROUND: The LMNA gene, one of 6 autosomal disease genes implicated in familial dilated cardiomyopathy, encodes lamins A and C, alternatively spliced nuclear envelope proteins. Mutations in lamin A/C cause 4 diseases: Emery-Dreifuss muscular dystrophy, limb girdle muscular dystrophy type 1B, Dunnigan-type familial partial lipodystrophy, and dilated cardiomyopathy. METHODS AND
RESULTS: Two 4-generation white families with autosomal dominant familial dilated cardiomyopathy and conduction system disease were found to have novel mutations in the rod segment of lamin A/C. In family A a missense mutation (nucleotide G607A, amino acid E203K) was identified in 14 adult subjects; disease was manifest as progressive conduction disease in the fourth and fifth decades. Death was caused by heart failure. In family B a nonsense mutation (nucleotide C673T, amino acid R225X) was identified in 10 adult subjects; disease was also manifest as progressive conduction disease but with earlier onset (third and fourth decades), ventricular dysrhythmias, left ventricular enlargement, and systolic dysfunction. Death was caused by heart failure and sudden cardiac death. Skeletal muscle disease was not observed in either family.
CONCLUSIONS: Novel rod segment mutations in lamin A/C cause variable conduction system disease and dilated cardiomyopathy without skeletal myopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561226     DOI: 10.1054/jcaf.2001.26339

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  32 in total

1.  Left ventricular noncompaction in a family with lamin A/C gene mutation.

Authors:  John J Parent; Jeffrey A Towbin; John L Jefferies
Journal:  Tex Heart Inst J       Date:  2015-02-01

Review 2.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females.

Authors:  Wenting Chen; Jianhua Huo; Aiqun Ma; Ling Bai; Ping Liu
Journal:  Mol Cell Biochem       Date:  2013-06-22       Impact factor: 3.396

Review 4.  Diseases of the nuclear envelope.

Authors:  Howard J Worman; Cecilia Ostlund; Yuexia Wang
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 5.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

6.  Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

Authors:  Chad Brodt; Jill D Siegfried; Mark Hofmeyer; Jose Martel; Evadnie Rampersaud; Duanxiang Li; Ana Morales; Ray E Hershberger
Journal:  J Card Fail       Date:  2013-04       Impact factor: 5.712

7.  Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling.

Authors:  Monika Zwerger; Diana E Jaalouk; Maria L Lombardi; Philipp Isermann; Monika Mauermann; George Dialynas; Harald Herrmann; Lori L Wallrath; Jan Lammerding
Journal:  Hum Mol Genet       Date:  2013-02-19       Impact factor: 6.150

Review 8.  Sumoylation and human disease pathogenesis.

Authors:  Kevin D Sarge; Ok-Kyong Park-Sarge
Journal:  Trends Biochem Sci       Date:  2009-03-11       Impact factor: 13.807

Review 9.  SUMO--a post-translational modification with therapeutic potential?

Authors:  Chang-Hoon Woo; Jun-Ichi Abe
Journal:  Curr Opin Pharmacol       Date:  2010-01-14       Impact factor: 5.547

10.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

Authors:  Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger
Journal:  Am Heart J       Date:  2008-03-12       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.